CORT
Corcept Therapeutics Incorporated · Healthcare
Chief Development Officer William Guyer sold $463K of Corcept Therapeutics Incorporated
Sold$462,800
$46.28Price
10,000Shares
−63%Stake
What CORT did after the filing
- The stock from Fri, Oct 4 open, $45.10
- +14.9%
- S&P 500, same days
- +2.3%
Measured over 30 trading days, to the Nov 15 close.
Traded Tue, Oct 1. Filed Thu, Oct 3, 4:27 PM ET, after the close. Returns use the Oct 4 open and the Nov 15 close. Not investment advice.